Michael Moritz Unplugged: Jamming with a VC Star at Xconomy’s First San Francisco Event

Michael Moritz, a partner at leading venture firm Sequoia Capital since 1986, has been described as the most powerful venture capitalist in Silicon Valley. Routinely ranked at or near the top of Forbes’ Midas List of wealth creators, Moritz has led Sequoia’s investments in Google, Yahoo, PayPal, YouTube, Zappos, Kayak, Sugar, and many other companies. … Continue reading “Michael Moritz Unplugged: Jamming with a VC Star at Xconomy’s First San Francisco Event”

EMC’s Innovation Steward: CTO Jeff Nick Talks Company Strategy Amid Soaring Profits, Rumors of Big Acquisition

It has been a ridiculously busy week for EMC—and for everyone else, it seems. For starters, the Hopkinton, MA-based data storage giant (NYSE: [[ticker:EMC]]) announced record quarterly revenues for the third quarter of 2010. Yesterday the firm hosted its fourth annual innovation conference from its center in Cork, Ireland—which amounted to a company-wide session on … Continue reading “EMC’s Innovation Steward: CTO Jeff Nick Talks Company Strategy Amid Soaring Profits, Rumors of Big Acquisition”

Metabolic Solutions Development Grabs Venture Dollars For Diabetes Drugs, Gets New CEO

It’s a happy day for Metabolic Solutions Development. The Kalamazoo, MI-based firm said today it has reeled in $23.5 million to fund development of its experimental drug for Type 2 diabetes and its other treatments for metabolic diseases. It also announced the appointment of Stephen Benoit as its new chief executive. Hopen Life Sciences, a … Continue reading “Metabolic Solutions Development Grabs Venture Dollars For Diabetes Drugs, Gets New CEO”

RPI Raises $5M More from Riverlake Partners, Huntington Capital

Tukwila, WA-based digital-to-physical media company RPI has raised an additional $5 million financing round led by Portland, OR-based Riverlake Partners, with participation from its previous investor, San Diego-based Huntington Capital, the company said today. RPI has quite an interesting story. One of the few veteran mid-sized companies left in the Seattle area, RPI has been … Continue reading “RPI Raises $5M More from Riverlake Partners, Huntington Capital”

Tech Stories We Missed: A Roundup of Stories That May Not Have Made the News the First Time Around

It’s been quite a busy week here for Northwest-area technology companies and entrepreneurs. There haven’t been a particularly high number of straight deals, but while flipping through my notebook this week, I realized that there’s been a lot of smaller news that speaks to some interesting trends and happenings. —Portland, OR-based social e-commerce company ShopIgniter … Continue reading “Tech Stories We Missed: A Roundup of Stories That May Not Have Made the News the First Time Around”

Dicerna Gets Glaxo’s SR One to Join Investor Syndicate

[Corrected—10/22/10 at 6:25 am ET. See editor’s note] Watertown, MA-based Dicerna Pharmaceuticals said this morning it has brought in $4 million from SR One, the venture capital arm of London-based drug giant GlaxoSmithKline. The funding makes Glaxo’s SR One the latest big-name investor to buy into Dicerna’s new approach to silencing disease-related genes to treat … Continue reading “Dicerna Gets Glaxo’s SR One to Join Investor Syndicate”

Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News

FDA regulatory moves turned out to be the biggest news items over the past week, prompting San Diego’s Amylin Pharmaceuticals and CareFusion to respond separately to the agency’s actions. Get our latest assessment here, along with updates on venture funding, CEO pay, and the new museum-quality home for San Diego’s Avalon Ventures. —Investors hammered San … Continue reading “Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News”

Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal

[Corrected—10/22/10 at 6:30 am ET. See editor’s note.] Those of us who follow Cambridge, MA-based Alnylam Pharmaceuticals (NASDAQ:[[ticker:ALNY]]]) have come to expect the biotech to land major deals with large drug makers related to its gene-silencing drugs. The firm’s pacts with Novartis, Roche, Takeda Pharmaceutical, and others have been the envy of the biotech industry … Continue reading “Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal”

Zoho, Where Engineers Reign, Rewrites the Rules of Office Software

It would be easy to say that Zoho, whose online office productivity software has attracted 3 million users, is the worst nightmare for desktop software makers like Microsoft and even for a newer generation of Software-as-a-Service companies like Salesforce.com. But Zoho is more complicated than that. To figure in its competitor’s nightmares, Zoho would have … Continue reading “Zoho, Where Engineers Reign, Rewrites the Rules of Office Software”

Intellectual Ventures’ Med-Tech Foray, PATH Takes Ultra Rice to Africa, Mirador Gets FDA OK, & More Seattle-Area Life Sciences News

We had a hodgepodge of news this week on the biotech scene, with financings, an FDA approval, and an exclusive feature on what Nathan Myhrvold’s invention shop is doing in the medical device business. Get caught up here. —Cell Therapeutics (NASDAQ: [[ticker:CTIC]]), the Seattle-based cancer drug developer, raised $21 million through the sale of preferred … Continue reading “Intellectual Ventures’ Med-Tech Foray, PATH Takes Ultra Rice to Africa, Mirador Gets FDA OK, & More Seattle-Area Life Sciences News”

Compendia Bioscience Morphs Into Big Pharma’s Cancer Genomics Partner

Compendia Bioscience has evolved significantly since it spun out of the University of Michigan with its cancer genomics research software four years ago. Instead of just selling software and moving on to the next customer, Compendia co-founder and CEO, Daniel Rhodes, says that his firm has prospered by forming close ties to pharmaceutical companies that … Continue reading “Compendia Bioscience Morphs Into Big Pharma’s Cancer Genomics Partner”

With Boston Pilot Project, Next Step Living Aims to Show Energy Efficiency Retrofits Aren’t Only for the Wealthy

Retrofitting homes for energy efficiency may not be as expensive or unattainable as consumers may think, says Next Step Living founder and CEO Geoff Chapin. His Boston-based startup is working to bring energy improvements to more households by helping consumers making sense of the array of rebates and financial incentives available for such home renovations, … Continue reading “With Boston Pilot Project, Next Step Living Aims to Show Energy Efficiency Retrofits Aren’t Only for the Wealthy”

Optify Raises $6.1M More From Triangle Peak, Madrona, and Angels

Seattle-based search engine optimization (SEO) and social media software startup Optify has raised $6.1 million in a Series B round led by Triangle Peak Partners, the company said today. Seattle-based Madrona Venture Group, and a number of prominent angel investors, including Upstage Ventures founder Mark Wachen, former Microsoftie Bill Baker, Alexrod Capital Management founder Alan … Continue reading “Optify Raises $6.1M More From Triangle Peak, Madrona, and Angels”

Spark Capital Gathers $360M Worth of Kindling, 1366 Technologies Nabs $20M, NinePoint Medical Pinpoints $33M, & More Boston-Area Deals News

IT companies dominated this week’s deals news in New England. Here are some highlights. —Online videogame maker Quick Hit raised $2.5 million in equity financing, according to an SEC filing. The Foxborough, MA-based startup, which has a deal with the National Football League to used official team names, logos, and uniforms for its football role-playing … Continue reading “Spark Capital Gathers $360M Worth of Kindling, 1366 Technologies Nabs $20M, NinePoint Medical Pinpoints $33M, & More Boston-Area Deals News”

Avalon Ventures’ Kevin Kinsella Remakes Private Copley Library in La Jolla

Kevin Kinsella moved to San Diego with his Ford Pinto in 1978. He still remembers driving shakily past the private library of newspaper publisher James S. Copley in the tony enclave of La Jolla, and thinking, “Wow.” To Kinsella, who graduated from MIT in 1967 with an undergraduate degree in management, “It looked like one … Continue reading “Avalon Ventures’ Kevin Kinsella Remakes Private Copley Library in La Jolla”

Amylin, Alkermes Shares Crash on Surprise FDA Smackdown

Investors are fuming today about the surprise rejection of the once-weekly diabetes drug developed by San Diego-based Amylin Pharmaceuticals (NASDAQ: [[ticker:AMLN]]), drug giant Eli Lilly, and Waltham, MA-based Alkermes (NASDAQ: [[ticker:ALKS]]). Amylin has the most at stake, and is taking the biggest hit today after news broke about the FDA’s refusal to approval exenatide once-weekly … Continue reading “Amylin, Alkermes Shares Crash on Surprise FDA Smackdown”

PATH Snags $1M Federal Grant to Take Ultra Rice to Africa

One of the cool projects that PATH has been working on for years to put a dent in global malnutrition just got a significant boost in the place it could have its biggest impact—Africa. PATH, the global health hothouse with headquarters in Seattle, is announcing today it has received a $1 million grant from the … Continue reading “PATH Snags $1M Federal Grant to Take Ultra Rice to Africa”

Study Shows Startup Executive Pay on the Mend

A study of private information technology and life sciences companies shows that tech executive pay is recovering from a dismal 2009. And it provides the public a rare glimpse at how much executives at startups are paid; that’s information privately held firms don’t have to divulge to the SEC, as public companies do. The CompStudy—completed … Continue reading “Study Shows Startup Executive Pay on the Mend”

The Challenge of Understanding Biotech: Sifting Through the Fog and Jargon

I recently enjoyed reading two books on the mortgage meltdown, “The Big Short” by Michael Lewis and Gregory Zuckerman’s “The Greatest Trade Ever.” They each provided a detailed post-mortem on the implosion of the housing bubble. What fascinated me most about their accounts was how virtually everyone on Wall Street, with a few notable exceptions, … Continue reading “The Challenge of Understanding Biotech: Sifting Through the Fog and Jargon”

CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis

One of the interesting new ideas in the treatment of autoimmune disease is approaching a critical turning point at San Diego-based CalciMedica. This little company, so close to the ocean you can smell it from the CEO’s office window, is based in part on some intriguing science that got its start at the Immune Disease … Continue reading “CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis”

Exelixis Seeks to Climb From the Penalty Box, Prove its Lead Drug Still Has Legs

Mike Morrissey had plenty of headaches when he took over as CEO of South San Francisco-based Exelixis (NASDAQ: [[ticker:EXEL]]). Two weeks before he took the job, Bristol-Myers Squibb (NYSE: [[ticker:BMY]]) dropped a bomb by saying it was walking away from its 50 percent ownership stake in Exelixis‘ most important cancer drug candidate. CEO George Scangos … Continue reading “Exelixis Seeks to Climb From the Penalty Box, Prove its Lead Drug Still Has Legs”

Bezos-Backed Doxo Rolls Out Free Paperless Bill Management Service

There’s been a lot of buzz around Seattle about Doxo lately. And yet, the startup has managed to maintain some stealthiness around what it actually does—despite the fact that it has some big names involved. The company has ex-Qpass dream-team Steve Shivers, Roger Parks, and Mark Goris (also known as the “Qpass mafia“) for founders. … Continue reading “Bezos-Backed Doxo Rolls Out Free Paperless Bill Management Service”

Turning “Black Silicon” Into Gold: SiOnyx Closes $12.5M from Bay Area and Seattle Firms, Goes After Image Sensor Market

Quick, name a semiconductor company in the Boston area that’s been getting lots of venture financing lately. OK, well, you already read the headline, so that one doesn’t count. My point is, there haven’t been too many of those—until today. SiOnyx is the Beverly, MA-based semiconductor materials company that is working on commercializing so-called “black … Continue reading “Turning “Black Silicon” Into Gold: SiOnyx Closes $12.5M from Bay Area and Seattle Firms, Goes After Image Sensor Market”

Genomatica Gets Patents for “Sustainable” Methods to Make Nylon Precursor

San Diego-based Genomatica, which has been developing “green” ways of using microbes to produce an industrial chemical called 1, 4 butanediol (BDO), said Tuesday the U.S. Patent and Trademark Office has granted it two foundational patents for another key industrial chemical— adipic acid. Adipic acid is used to make nylon, and it has existing market … Continue reading “Genomatica Gets Patents for “Sustainable” Methods to Make Nylon Precursor”

Amylin, Alkermes Once-Weekly Diabetes Drug Fails to Win FDA Approval

Bad news out tonight for followers of San Diego-based Amylin Pharmaceuticals, drug giant Eli Lilly, and Waltham, MA-based Alkermes. The new diabetes drug that all three companies have been counting on as a future revenue driver—the once-weekly injectable version of exenatide (Bydureon)—failed to win clearance from the FDA as a new treatment available for sale … Continue reading “Amylin, Alkermes Once-Weekly Diabetes Drug Fails to Win FDA Approval”

1366 Technologies Gets $20M Round to Move Solar Tech into Production

1366 Technologies has the cash to advance toward production of technology that could reduce the cost of solar energy. The Lexington, MA-based firm said today it has brought in $20 million in Series B funding, including investments from Korea-based Hanwha Chemical and the European cleantech investor Ventizz Capital Fund. Those new investors joined previous backers … Continue reading “1366 Technologies Gets $20M Round to Move Solar Tech into Production”

Sequoia Leads $20 Million Round for Evernote—Q&A with CEO Phil Libin

Evernote, the Mountain View, CA, startup building a multiplatform service that helps consumers organize and retrieve all the digital bric-a-brac in their lives, has just taken a big step forward, raising $20 million in a Series C investment round led by top-tier venture firm Sequoia Capital. Some 4.7 million people use Evernote’s freemium service, which … Continue reading “Sequoia Leads $20 Million Round for Evernote—Q&A with CEO Phil Libin”

How’s Your Salary? Detroit Area Wages Still Down After Signs of Recovery

If you’re feeling squeezed by the recession, you’re obviously not alone. Since the bottom fell out of the economy in 2009, the Detroit metro area in particular has been struggling to regain its footing when it comes to jobs and wages. Now, after a promising start to 2010, things might be heading downhill again. That’s … Continue reading “How’s Your Salary? Detroit Area Wages Still Down After Signs of Recovery”

Andy Sack, the Jack of All Startup Trades, Joins VC Crossfire Panel Oct. 28

There might not be anyone else in Seattle pursuing more tech startup ideas, through more different financial avenues, than Andy Sack. He’s one of the key players at three organizations that seek to invest and help foster more high-impact tech companies in Seattle—Founder’s Co-op, TechStars, and RevenueLoan. And now he’s agreed to share his latest … Continue reading “Andy Sack, the Jack of All Startup Trades, Joins VC Crossfire Panel Oct. 28”

TalentSpring Acquired by Talent Technology

Seattle-based TalentSpring has been acquired by Richmond, B.C.-based recruitment and hiring software company Talent Technology, according to a statement released today. Financial terms of the deal were not disclosed.

TalentSpring is a semantic-search software developer that helps job recruiters better match candidates to open positions. To date, the company has raised $2.7 million in financing from Second Avenue Partners and private investors. TalentSpring’s system gives employers access to over 120 million resumes, aggregating information from Monster, CareerBuilder, HotJobs, and Dice, alongside niche job boards, social networks, the Web, and the company’s internal resume database.

Clovr, With New Seed Funding, Looks to Bridge Gaps Between Banks, Advertisers, “Loyalty 2.0”

What do you get when you mix a digital media and marketing entrepreneur with a banking and real estate executive? Answer: Clovr Media, a Boston company that’s officially launching today with $1.5 million in seed funding from Kepha Partners and CommonAngels. Founded by Tom Burgess, the former CEO of Third Screen Media, and Doug Spear, … Continue reading “Clovr, With New Seed Funding, Looks to Bridge Gaps Between Banks, Advertisers, “Loyalty 2.0””

AudioPress, Packaging Podcasts & Streaming Radio For People Stuck in Traffic, Seeks to Tap Fast-Growing Market

Something like 50 million Americans spend at least an hour a day commuting to work, which is a lot of people and a lot of time. For entrepreneurs who aspire to deliver audio content over the wireless Web, this is turning into a huge market of potential consumers up for grabs. More and more of … Continue reading “AudioPress, Packaging Podcasts & Streaming Radio For People Stuck in Traffic, Seeks to Tap Fast-Growing Market”

Siluria, Based on MIT Research, Raises $13.3M For Cleaner, Cheaper Plastics

Siluria Technologies, the San Francisco startup developing a low-emissions technique for making the world’s most widely used commodity chemical in plastics, has raised its first big venture round to pursue an idea that has eluded the petrochemical industry for decades. The company, built on technology from Angela Belcher’s materials science lab at MIT, is announcing … Continue reading “Siluria, Based on MIT Research, Raises $13.3M For Cleaner, Cheaper Plastics”

San Diego’s Top 10 Deals: Q3 VC Funding Still Strongly Favors Life Sciences

Venture funding for high tech companies made a stronger showing during the third quarter, but life science deals still accounted for more than half the capital invested in the San Diego area, according to the latest MoneyTree Report. Venture investments in local biotech, medical diagnostics, and device companies also made up the most of the … Continue reading “San Diego’s Top 10 Deals: Q3 VC Funding Still Strongly Favors Life Sciences”

Halosource’s $80M IPO, Avelle Raises $1M, NW Cleantech Ideas Compete in GE Ecomagination Challenge, and More Seattle-Area Deals News

The last few weeks have been slow on deals for Seattle-area technology companies, but that doesn’t mean there haven’t been some interesting ones to watch. Take a look at the highlights: —Just a few days after we ran a story about the business’s strategy moving forward, Bellevue, WA-based mobile software company Motricity (NASDAQ: [[ticker: MOTR]]) … Continue reading “Halosource’s $80M IPO, Avelle Raises $1M, NW Cleantech Ideas Compete in GE Ecomagination Challenge, and More Seattle-Area Deals News”

For Critical Signal Technologies, An Aggressive Approach to Growing the Telehealth Industry

Jeffery Prough, CEO of Critical Signal Technologies, is taking an alternative approach to reforming the healthcare system. Instead of getting caught up in political debate, Prough is using his business to try to improve healthcare conditions. Critical Signal, the Farmington Hills, MI-based company that Prough founded in 2006, is already one of the five largest … Continue reading “For Critical Signal Technologies, An Aggressive Approach to Growing the Telehealth Industry”

Where Bras Meet Software: Zyrra Raises Money From Jess McLear, Jean Hammond, & Local Angels For Its Bra Industry “Revolution”

Derek Ohly is known as the “bra guy,” both around the office at MassChallenge, the startup accelerator and entrepreneur competition, and throughout the Boston-area investor community, he says. “I didn’t expect to end up in the world of bras, and here I am,” says Ohly, a graduate of Babson College’s MBA program (a likely story). … Continue reading “Where Bras Meet Software: Zyrra Raises Money From Jess McLear, Jean Hammond, & Local Angels For Its Bra Industry “Revolution””

ReVision Planning Late-Stage Trial Next Year for Macular Degeneration Drug

San Diego’s ReVision Therapeutics got an encouraging reception over the weekend at a joint meeting in Chicago of the American Academy of Opthalmology and the Middle East-Africa Council of Opthalmology. Researchers led by Dr. Jason Slakter of the New York University School of Medicine presented results from a mid-stage clinical trial of an experimental drug … Continue reading “ReVision Planning Late-Stage Trial Next Year for Macular Degeneration Drug”

Ray Ozzie to Step Down as Microsoft Chief Software Architect

Microsoft’s chief software architect, Ray Ozzie, will be stepping down from the position after an undefined transitional period, according to Microsoft chief executive Steve Ballmer. Ballmer made the announcement via an e-mail sent out to Microsoft employees today, adding that he had no plans to fill Ozzie’s vacated position. “The CSA role was unique and … Continue reading “Ray Ozzie to Step Down as Microsoft Chief Software Architect”

Aastrom Gets FDA Fast Track Status, Gears Up for Pivotal Study of Cell Therapy

Aastrom Biosciences is gearing up for a definitive test of a first-of-its-kind regenerative medicine that uses adult stem cells. The Ann Arbor, MI-based biotech company said today it has gotten the FDA’s “fast track” designation for its pivotal clinical trial plan of a treatment that it hopes will help people with severe cardiovascular disease to … Continue reading “Aastrom Gets FDA Fast Track Status, Gears Up for Pivotal Study of Cell Therapy”

‘Anything That’s $1B is Good,’ and Other Gems From the Media Lab’s 25th Bash

I spent a good part of Friday at the MIT Media Laboratory, which was packed to the rafters with faculty, alums, and other guests celebrating the pioneering institution’s 25th anniversary. Below are some quick impressions from the morning’s activities and an afternoon chat with Google CEO Eric Schmidt conducted by public radio host John Hockenberry. … Continue reading “‘Anything That’s $1B is Good,’ and Other Gems From the Media Lab’s 25th Bash”

Mark Zuckerberg Goes to Startup School [Video]

In one of his first major public appearances since the release of The Social Network, Facebook co-founder and CEO Mark Zuckerberg spoke onstage at Stanford this Saturday about why he started the company, why he moved it to Silicon Valley, and what he thinks about the controversial movie. (The gist of his review: amusing but … Continue reading “Mark Zuckerberg Goes to Startup School [Video]”

Qualcomm Looks for Synergies With Tech Coast Angels’ Annual Quick Pitch Event to Spur Employee Entrepreneurship

Qualcomm (NASDAQ: [[ticker:QCOM]]) has begun to work more closely with Southern California’s Tech Coast Angels as part of an internal effort to promote an entrepreneurial culture at the San Diego wireless giant and to encourage employees to bring their ideas for innovations forward. The company’s new focus on entrepreneurship and closer ties with Tech Coast … Continue reading “Qualcomm Looks for Synergies With Tech Coast Angels’ Annual Quick Pitch Event to Spur Employee Entrepreneurship”

The $100,000 Taxi Ride, the $403M Exit for Google Ventures and iFund, CarWoo Goes National, & More Bay Area BizTech News

Columbus Day made last week a short one, but I don’t think many San Francisco or Silicon Valley innovators pay attention to this particular holiday, as there was no shortage of technology and business news. —My colleague Erin published a nice scoop about Baydin, a Cambridge, MA-based maker of e-mail management software whose founder won … Continue reading “The $100,000 Taxi Ride, the $403M Exit for Google Ventures and iFund, CarWoo Goes National, & More Bay Area BizTech News”

Intellectual Ventures’ Latest Big Push: Turning Med-Tech Inventions Into Cash

Nathan Myhrvold is a physicist who made his name as a software guy at Microsoft. So it’s natural to think that if his Bellevue, WA-based invention firm, Intellectual Ventures, creates anything of lasting value, it will probably come from physics or software. Maybe it will be something really offbeat (fighting infectious disease with mosquito-zapping lasers), … Continue reading “Intellectual Ventures’ Latest Big Push: Turning Med-Tech Inventions Into Cash”

Shape Up The Nation Wants People to Let Their Friends Help Them Lose Weight

It’s not often that companies offer a reporter his choice of an orange, clementine, banana, or energy bar when he arrives to do an interview. But on a recent visit to the Providence, RI, headquarters of Shape Up The Nation, which dishes out wellness programs on its social networking platform, the staffers were eager to … Continue reading “Shape Up The Nation Wants People to Let Their Friends Help Them Lose Weight”

NW Energy Angel Kiki Tidwell Seeks to Professionalize Angel Investing Through Kauffman Fellowship

Kiki Tidwell, when she was growing up, had planned on entering the family business. She was raised in Hawaii, and throughout her childhood she and her parents traveled to Aspen, CO often to tend to the family restaurant. When Tidwell graduated high school, she enrolled in the hotel and restaurant management program at the University … Continue reading “NW Energy Angel Kiki Tidwell Seeks to Professionalize Angel Investing Through Kauffman Fellowship”

VCs Making Smaller Investments, V-Vehicle Restarting Under New CEO, Qualcomm Buys iSkoot, & More San Diego BizTech News

A common theme in last week’s technology news is how companies and entire industries continually remake their businesses, whether it’s the venture capital community, startup carmakers, or a San Diego company that specializes in data storage technology. Read on to see what I mean. —As the venture capital survey data comes in from the three … Continue reading “VCs Making Smaller Investments, V-Vehicle Restarting Under New CEO, Qualcomm Buys iSkoot, & More San Diego BizTech News”

Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker

Quite a few biotech entrepreneurs would be happy to trade places with Sangamo Biosciences founder and CEO Ed Lanphier. His company has a hammerlock on the intellectual property for a leading-edge genetic technology that a lot of academic scientists love to write about in top peer-reviewed journals like Nature. Big partners like Dow Chemical and … Continue reading “Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker”